Literature DB >> 17721698

Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus.

Majidreza Kamyar1, B Julienne Johnson, John J McAnaw, Rosa Lemmens-Gruber, Steve A Hudson.   

Abstract

OBJECTIVE: The study aimed to assess adherence of prescribed medication in primary care to nationally recognised guideline criteria using case note review applying a previously developed medication assessment tool for coronary heart disease (MAT-CHD). Setting Primary care medical centre serving 17,991 patients. A sample of 208 from 463 patients with type 2 diabetes aged 20-75 years with or without a history of ischaemic heart disease (IHD).
METHOD: Patients' records were accessed via medical and pharmacy databases. The criteria of the 23-item audit tool were applied to medical records from case notes in order to quantify adherence to individual guideline criteria. MAIN OUTCOME MEASURE: Frequency of adherence to agreed definitions of medication use quality criteria.
RESULTS: A total of 1,433 guideline criteria were applied and 1,107 (77.2%, CI: 75.0, 79.4) criteria standards were met with 326 (22.7%, CI: 20.6, 25.0) non-adherences. The overall adherence to guideline criteria was significantly lower for secondary prevention than for primary prevention (74.4 vs. 80.1%, P<0.05; Chi square). Justification recorded in the case notes was identified for 54 (17%, CI: 13, 21) of those non-adherences.
CONCLUSION: The MAT-CHD highlighted areas for review and possible improvement. The tool can be used in primary care from case record examination and offers a means of co-operation between community pharmacists and general practitioners in clinical guideline implementation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721698     DOI: 10.1007/s11096-007-9154-7

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  10 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Lifetime health effects and costs of diabetes treatment.

Authors:  L W Niessen; R Dijkstra; R Hutubessy; G E H M Rutten; A F Casparie
Journal:  Neth J Med       Date:  2003-11       Impact factor: 1.422

3.  EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.

Authors: 
Journal:  Eur Heart J       Date:  1997-10       Impact factor: 29.983

4.  The need for improved medical management of patients with concomitant hypertension and type 2 diabetes mellitus.

Authors:  Paul J Godley; Susan K Maue; Eileen W Farrelly; Feride Frech
Journal:  Am J Manag Care       Date:  2005-04       Impact factor: 2.229

Review 5.  Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies.

Authors:  Francesco Giorgino; Luigi Laviola; Anna Leonardini
Journal:  Diabetes Res Clin Pract       Date:  2005-04-13       Impact factor: 5.602

Review 6.  Adherence to treatment: the key for avoiding long-term complications of diabetes.

Authors:  Israel Lerman
Journal:  Arch Med Res       Date:  2005 May-Jun       Impact factor: 2.235

7.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

8.  NIDDM and its metabolic control predict coronary heart disease in elderly subjects.

Authors:  J Kuusisto; L Mykkänen; K Pyörälä; M Laakso
Journal:  Diabetes       Date:  1994-08       Impact factor: 9.461

9.  The Audit Commission review of diabetes services in England and Wales, 1998-2001.

Authors:  B Fitzsimons; L Wilton; T Lamont; L McCulloch; J Boyce
Journal:  Diabet Med       Date:  2002-07       Impact factor: 4.359

10.  The relationship between primary care physicians' adherence to guidelines for the treatment of diabetes and patient satisfaction: findings from a pilot study.

Authors:  Revital Gross; Hava Tabenkin; Avi Porath; Anthony Heymann; Miriam Greenstein; Boaz Porter; Ronit Matzliach
Journal:  Fam Pract       Date:  2003-10       Impact factor: 2.267

  10 in total
  9 in total

1.  Clinical characteristics, modalities and complications of diabetic patients with migration background at a Central European University Clinic.

Authors:  Ammon Handisurya; Dagmar Bancher-Todesca; Majid Reza Kamyar; Rosa Lemmens-Gruber; Alexandra Kautzky-Willer
Journal:  Wien Med Wochenschr       Date:  2011-03-07

2.  Medication assessment tool to detect care issues from routine data: a pilot study in primary care.

Authors:  Tobias Dreischulte; Julienne Johnson; John McAnaw; Marlies Geurts; Han de Gier; Steve Hudson
Journal:  Int J Clin Pharm       Date:  2013-12

3.  Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention.

Authors:  Beate Hennie Garcia; Lars Småbrekke; Thor Trovik; Trude Giverhaug
Journal:  Eur J Clin Pharmacol       Date:  2012-09-19       Impact factor: 2.953

4.  A medication assessment tool to evaluate prescribers' adherence to evidence-based guidelines in bipolar disorder.

Authors:  Dalal M Al-Taweel; Mohammad Alsuwaidan
Journal:  Int J Clin Pharm       Date:  2017-06-26

5.  Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria.

Authors:  Rosa Lemmens-Gruber; Christine Hahnenkamp; Ulrike Gössmann; Jürgen Harreiter; Majid-Reza Kamyar; Barbara Julienne Johnson; Steve Hudson; Alexandra Kautzky-Willer
Journal:  Int J Clin Pharm       Date:  2012-04-24

6.  Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait.

Authors:  Dalal M Al-Taweel; Abdelmoneim I Awad; B Julienne Johnson
Journal:  Int J Clin Pharm       Date:  2012-12-20

7.  Adherence to clinical guidelines in management of diabetes and prevention of cardiovascular disease in Qatar.

Authors:  Mohammad Issam Diab; B Julienne Johnson; Steve Hudson
Journal:  Int J Clin Pharm       Date:  2012-11-08

8.  Development and validation of medication assessment tools to evaluate prescribing adherence to evidence-based guidelines for secondary prevention of coronary heart disease in post-acute coronary syndromes patients in Kuwait.

Authors:  Dalal Al-Taweel; Abdelmoneim Awad
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

9.  Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study.

Authors:  Alexandra Kautzky-Willer; Kathrin Stich; Juliane Hintersteiner; Alexander Kautzky; Majid Reza Kamyar; Johannes Saukel; Julienne Johnson; Rosa Lemmens-Gruber
Journal:  Cardiovasc Diabetol       Date:  2013-05-24       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.